CRE Homepage About The CRE Advisory Board Newsletter Search Links Representation Comments/Ideas
Data Access
Data Quality
Regulation by Litigation
Regulation by Appropriation
Special Projects
CRE Watch List
OMB Papers
Abstracts and Reviews
Regulatory Review
Voluntary Standards Program
CRE Report Card
Public Docket Preparation
Consumer Response Service
Site Search

Enter keyword(s) to search

®: CRE Regulatory Action of the Week

FDA Seeks Regulatory Reform Comments
The U.S. Food and Drug Administration is reviewing several of its existing regulations. FDA is conducting this review pursuant to Executive Order 13771 entitled, "Reducing Regulation and Controlling Regulatory Costs," and Executive Order 13777 entitled, "Enforcing the Regulatory Reform Agenda". The FFDA seeks public comment on its regulatory review. Submit either electronic or written comments o by December 7, 2017.

  • Click here for relevant links and more detail.